Literature DB >> 22621222

Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens.

Helena Hůlková1, Milan Elleder.   

Abstract

AIMS: To identify reliable criteria with which to improve the diagnosis of lysosomal acid lipase (LAL) deficiency of the cholesterol ester storage disease (CESD) type in liver biopsies. METHODS AND
RESULTS: We analysed a series of 16 liver biopsies of LAL deficiency of the CESD type confirmed by enzyme testing and DNA sequencing. The biopsy appearances were compared with those of biopsies of other causes of fatty liver. A predominantly microvesicular steatosis in CESD patients could not be reliably distinguished from other causes of fatty liver with cytosolic lipid accumulation in fixed paraffin-embedded tissues routinely stained with haematoxylin and eosin. The presence of luminal (cathepsin D) and membrane lysosomal markers [lysosomal-associated membrane protein (LAMP)1, LAMP2, and lysosomal integral membrane protein 2] around the lipid vacuoles facilitated the diagnosis of CESD in fixed paraffin-embedded material. Additional diagnostic clues included autofluorescent detection of ceroid induction in storage macrophages and the absence of lipopigment in hepatocytes. Stored liquid crystals of cholesteryl esters, which are associated with Maltese cross-type birefringence, were best appreciated in unfixed biopsy samples.
CONCLUSIONS: The pathological diagnosis of CESD requires a high index of suspicion, and can be rapidly and effectively appreciated at the light microscopy level, even in routine fixed paraffin-embedded liver samples with immuohistochemical staining for lysosomal markers.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22621222     DOI: 10.1111/j.1365-2559.2011.04164.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  21 in total

Review 1.  Genetically modified mouse models to study hepatic neutral lipid mobilization.

Authors:  Guenter Haemmerle; Achim Lass
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-06-05       Impact factor: 5.187

2.  A systems biology approach utilizing a mouse diversity panel identifies genetic differences influencing isoniazid-induced microvesicular steatosis.

Authors:  Rachel J Church; Hong Wu; Merrie Mosedale; Susan J Sumner; Wimal Pathmasiri; Catherine L Kurtz; Mathew T Pletcher; John S Eaddy; Karamjeet Pandher; Monica Singer; Ameesha Batheja; Paul B Watkins; Karissa Adkins; Alison H Harrill
Journal:  Toxicol Sci       Date:  2014-05-20       Impact factor: 4.849

Review 3.  The role of sebelipase alfa in the treatment of lysosomal acid lipase deficiency.

Authors:  Angelika L Erwin
Journal:  Therap Adv Gastroenterol       Date:  2017-04-26       Impact factor: 4.409

Review 4.  Inborn errors of metabolism in the differential diagnosis of fatty liver disease.

Authors:  Yılmaz Yıldız; Hatice Serap Sivri
Journal:  Turk J Gastroenterol       Date:  2020-01       Impact factor: 1.852

Review 5.  Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review.

Authors:  Tyler J Severson; Siddesh Besur; Herbert L Bonkovsky
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

6.  Fatty Liver and Systemic Atherosclerosis in a Young, Lean Patient: Rule Out Lysosomal Acid Lipase Deficiency.

Authors:  Maria Zharkova; Tatiana Nekrasova; Vladimir Ivashkin; Marina Maevskaya; Tatyana Strokova
Journal:  Case Rep Gastroenterol       Date:  2019-12-04

7.  Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups.

Authors:  Stuart A Scott; Benny Liu; Irina Nazarenko; Suparna Martis; Julia Kozlitina; Yao Yang; Charina Ramirez; Yumi Kasai; Tommy Hyatt; Inga Peter; Robert J Desnick
Journal:  Hepatology       Date:  2013-07-29       Impact factor: 17.425

8.  Dyslipidaemia: Lysosomal acid lipase deficiency-a cautious leap forward.

Authors:  Carla E M Hollak; G Kees Hovingh
Journal:  Nat Rev Endocrinol       Date:  2015-10-27       Impact factor: 43.330

9.  Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat diet-induced kidney injury.

Authors:  Anne-Emilie Declèves; Zarazuela Zolkipli; Joseph Satriano; Lin Wang; Tomohiro Nakayama; Mihael Rogac; Thuy P Le; Joëlle L Nortier; Marilyn G Farquhar; Robert K Naviaux; Kumar Sharma
Journal:  Kidney Int       Date:  2013-12-04       Impact factor: 10.612

Review 10.  Neonatal Cholestasis - Differential Diagnoses, Current Diagnostic Procedures, and Treatment.

Authors:  Thomas Götze; Holger Blessing; Christian Grillhösl; Patrick Gerner; André Hoerning
Journal:  Front Pediatr       Date:  2015-06-17       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.